Evaluation of Immune Response against Leishmaniasis in BALB/c Mice Immunized with Cationic DOTAP/DOPE/CHOL Liposomes Containing Soluble Leishmania major Antigens

BACKGROUND: Whole killed Leishmania vaccine reached phase III clinical trials but failed to display significant efficacy in human mainly due to limited Th1 inducer adjuvant. Liposomes consisting of 1, 2-dioleoyl-3trimethylammonium-propane (DOTAP) bearing an inherent adjuvanticity and 1, 2-dioleoyl-L...

Descripción completa

Detalles Bibliográficos
Autores principales: HOJATIZADE, Mansure, BADIEE, Ali, KHAMESIPOUR, Ali, JAAFARI, Mahmoud Reza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tehran University of Medical Sciences 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6511587/
https://www.ncbi.nlm.nih.gov/pubmed/31123470

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6511587/
https://www.ncbi.nlm.nih.gov/pubmed/31123470

Ejemplares similares